Ridgeback Capital's book
6 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | $2.2B | — | — | |
| Crisp | — | $630.0M | — | — | |
| Arbor Biotechnologies | — | $238.9M | — | — | |
| Stratus Therapeutics | — | $210.0M | — | — | |
| Aro Biotherapeutics | — | $181.5M | — | — | |
| Hinge Bio | Drug Discovery | $46.0M | — | — |
Free account
See the whole book
- ·Watchlist + alerts for Ridgeback Capital's activity
Create free account
No card required